Low level determinations of methyl methanesulfonate and ethyl methanesulfonate impurities in Lopinavir and Ritonavir Active pharmaceutical ingredients by LC/MS/MS using electrospray ionization

Journal of Pharmaceutical and Biomedical Analysis

Volumn 55, Issue 2, 2011, Pages 379-384

  Kakadiya, P R ^a   Reddy, B Pratapa ^a   Singh, V ^a   Ganguly, S ^a   Chandrashekhar, T G ^a   Singh, D K ^b  

^a Ranbaxy Research Laboratory   (India)

^b HARCOURT BUTLER TECHNOLOGICAL INSTITUTE   (India)

Author keywords

Ethyl methanesulfonates; LC MS MS; Lopinavir; Methyl methanesulfonates; Ritonavir

Indexed keywords

LOPINAVIR; MESYLIC ACID ETHYL ESTER; MESYLIC ACID METHYL ESTER; RITONAVIR;

ACCURACY; ARTICLE; DRUG IMPURITY; DRUG SELECTIVITY; DRUG SENSITIVITY; ELECTROSPRAY MASS SPECTROMETRY; GENOTOXICITY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL; SIGNAL NOISE RATIO; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, LIQUID; ETHYL METHANESULFONATE; HIV PROTEASE INHIBITORS; LIMIT OF DETECTION; METHYL METHANESULFONATE; PYRIMIDINONES; REFERENCE STANDARDS; RITONAVIR; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 79952244798     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.01.039     Document Type: Article

References (15)

1. Temghare G.A., Shetye S.S., Joshi S.S. Rdrug substanced and sensitive method for quantitative determination of Lopinavir and Ritonavir in human plasma by Liquid Chromatography-Tandem Mass Spectrometry. J. Chem. 2009, 6:223-230.
2. Dobo K.L., Greene N., Cyr M.O., Caron S., Ku W.W. The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development. Regul. Toxicol. Pharm. 2006, 44:282-293.
3. IARC, Monographs Program on the Evaluation of Carcinogenic Risks to Humans for methyl methanesulfonate 71 (1999) 1059; IARC Monographs Program on the Evaluation of Carcinogenic Risks to Humans for ethyl methanesulfonate 7 (1974) 245.
4. Guideline on the Limits of Genotoxic Impurities, Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMEA), London, 28 June, 2006 (CPMP/SWP/5199/02, EMEA/CHMP/QWP/251344/2006).
5. Genotoxic and carcinogenic impurities in drug substances and products: recommended approaches. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Silver Spring, MD, USA, December 2008.
6. Kroes R., Renwick A.G., Cheeseman M., Kleiner J., Mangelsdorf I., Piersma A., Schilter B., Sclatter J., Van Schothorst F., Vos J.G., Wurtzen G. Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet. Food Chem. Toxicol. 2004, 42:65-83.
7. S.A. Miller, J. Ju, M. Cucolo, J.Y. Dai, J. Jia, K. Narra, A.M. Smith, A.F. Aubrey, Poster at the 52nd ASMS Conference, 2004.
8. Filby W.G., Gunther K., Penzhorn R.D. Relative molar response of a flame ionization detector to some organic compounds containing sulfur. Anal. Chem. 1975, 47:2283-2285.
9. Li W. Trace analysis of residual methyl methanesulfonate, ethyl methanesulfonate and isopropyl methanesulfonate in pharmaceuticals by cdrug substancellary gas chromatography with flame ionization detection. J. Chromatogr. A 2004, 1046:297-301.
10. Ramakrishna K., Raman N.V.V.S.S., Narayana Rao K.M.V., Prasad A.V.S.S., Subhaschander Reddy K. Development and validation of GC-MS method for the determination of methyl methanesulfonate and ethyl methanesulfonate in imatinib mesylate. J. Pharm. Biomed. Anal. 2008, 46:780-783.
11. Colon I., Richoll S.M. Determination of methyl and ethyl esters of methanesulfonic, benzenesulfonic and p-toluenesulfonic acids in active pharmaceutical ingredients by solid-phase microextraction (SPME) coupled to GC/SIM-MS. J. Pharm. Biomed. Anal. 2005, 39:477-485.
12. Lee C.R., Guivarch F., Van Dau C.N., Tessier D., Krstulovic A.M. Determination of polar alkylating agents as thiocyanate/isothiocyanate derivatives by reaction headspace gas chromatography. Analyst 2003, 128:857-863.
13. Alzaga R., Ryan R.W., Taylor-Worth K., Lipczynski A.M., Szucs R., Sandra P. A generic approach for the determination of residues of alkylating agents in active pharmaceutical ingredients by in situ derivatization-headspace-gas chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 2007, 45:472-479.
14. An J., Sun M., Bai L., Chen T., Liu D.Q., Kord A. A practical derivatization LC/MS approach for determination of trace level alkyl sulfonates and dialkyl sulfates genotoxic impurities in drug substances. J. Pharm. Biomed. Anal. 2008, 48:1006-1010.
15. ICH Q2B: Validation of analytical procedures: methodology, in: International Conference on Harmonization, Fed. Reg. (62 FR 27463), 19 May 1997.